Statins in heart failure-where do we stand? - Wikidata - wikimedia - TriplyDB

Statins in heart failure-where do we stand?

Statins in heart failure-where do we stand?

http://www.wikidata.org/entity/Q37817055

about

Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.Low circulating coenzyme Q10 during acute phase is associated with inflammation, malnutrition, and in-hospital mortality in patients admitted to the coronary care unit.

P2860

Q34429685-FCE10CA7-1184-4A6E-866A-00B3D29504EB Q51273186-F28B37A0-701D-4377-8154-D116ECE4DF0E

P2860

Statins in heart failure-where do we stand?

http://www.wikidata.org/entity/Q37817055

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Statins in heart failure-where do we stand?

@en

Statins in heart failure-where do we stand?

@nl

type

label

Statins in heart failure-where do we stand?

@en

Statins in heart failure-where do we stand?

@nl

prefLabel

Statins in heart failure-where do we stand?

@en

Statins in heart failure-where do we stand?

@nl

P1433

Q37817055-13D3524D-BCBA-419C-845B-E248150E0994

P1476

Q37817055-9854A0C7-587E-4638-9C43-E8DAF1E1674E

P2093

Q37817055-6359F5D4-FB64-4D49-9C1F-8157DC041B17

Q37817055-C48090C4-FAAE-448A-9F9C-1274189E9C93

Q37817055-EF4D0CF8-2BB0-45F8-86E5-2AA2BAD72820

P2860

Q37817055-004A9780-16F7-4CFC-8470-74186CCD22D9

Q37817055-009CC2D3-181E-4326-BF60-1BE7BD11B583

Q37817055-01EC39EF-2BEA-467A-8546-A203A13BC4F5

Q37817055-0BCB19C4-67B0-4180-A8F7-58F8382F684A

Q37817055-15B23026-02A3-4472-898E-0B383ABE0E17

Q37817055-1BE6C0FF-5E34-4E0A-978F-323508425E57

Q37817055-21461684-11E8-4215-A250-A7C0847DAF40

Q37817055-248CBEA0-8A25-40FA-BEB3-235D671B57A5

Q37817055-256E988F-20E1-4922-AB49-E54E91F4B7D7

Q37817055-25F8B46D-9213-49A5-A7F1-4D78B4CD2E31

P304

Q37817055-23AF3777-2BEB-471C-9C4B-544857282B58

P31

Q37817055-04FD4657-F669-4C96-8FCA-C2CE64F236FD

Q37817055-493cced2-1728-46ac-8d2c-f46774137aac

P356

Q37817055-2D693C18-2E08-4648-BEDF-4BDA8BE3FF2E

P433

Q37817055-17891C0B-02F9-42EA-A284-F91257662C6B

P478

Q37817055-A81FC00F-F7A8-4DB2-B6EE-9084A3605611

P577

Q37817055-6DB99989-DBC9-41A5-825B-AAC9B4A26F5B

P5875

Q37817055-F09EBABD-A577-471A-B500-0B2166EACDEE

P698

Q37817055-2307DFBA-E8E5-4F4B-A0A6-556A687DEBC6

P921

Q37817055-5DE9A54C-A3CF-4D6D-AAB2-3A0AC58FA3CE

P356

S10557-010-6269-1

P1433

Cardiovascular Drugs and Therapy

P1476

Statins in heart failure-where do we stand?

@en

P2093

Gary E McVeigh

http://www.w3.org/2001/XMLSchema#string

Kristopher S Lyons

http://www.w3.org/2001/XMLSchema#string

Mark T Harbinson

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

Fundamentals of endothelial function for the clinical cardiologist.

Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction.

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.

P304

99-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10557-010-6269-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49662742

http://www.w3.org/2001/XMLSchema#string

P698

21136284

http://www.w3.org/2001/XMLSchema#string

P921